Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lorazepam for Catatonia in Nodding Syndrome
NCT02462109Phase 1Completed
- Sponsor
- Makerere University
- Start
- Mar 2013
- Primary completion
- Mar 2013
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of lorazepam in catatonia, sponsored by Makerere University. Primary endpoint: Positive response to catatonia test at 60 months. Started Mar 2013; status: completed.
02
Drugs
lorazepam
03
Conditions
catatonia
Beyond the preview
Go deeper on NCT02462109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02462109.